Chapter 1

FIGO Staging and WHO Risk Scoring and Chemotherapy

Screenshot 2024-01-12 at 5.28.02 PM.png

Screenshot 2024-01-12 at 5.29.14 PM.png

Screenshot 2024-01-12 at 5.29.22 PM.png

Screenshot 2024-01-12 at 5.36.26 PM.png

Screenshot 2024-01-12 at 5.36.34 PM.png

Screenshot 2024-01-12 at 5.36.41 PM.png

Screenshot 2024-01-12 at 5.36.47 PM.png

Screenshot 2024-01-12 at 5.36.53 PM.png

Screenshot 2024-01-12 at 5.37.00 PM.png

Screenshot 2024-01-12 at 5.37.21 PM.png

Screenshot 2024-01-12 at 5.37.29 PM.png

Screenshot 2024-01-12 at 5.37.39 PM.png

The staging and scoring and chemotherapy mix.

Tasks:

Day 4 to 5: go through the images provided and familiarize the levels of staging; parameters and interpretation of the risk scoring for GTN patients; chemotherapeutic regimens and chemotoxicities in GTN; and read the journals listed under the resources tab.

Lesson Time Frame: 2 days

NCCN Guidelines for GTN version 2022.pdf
2021 FIGO CANCER REPORT Diagnosis and management of GTD.pdf
2021 EIRIKSSON_SOGC Guideline No. 408/ Management of GTD.pdf
2021 HOROWITZ_SGO Recommendations.pdf
2020 LOK_Clinical Guidelines of EOTTD for GTD.pdf
2021 HAO_Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk GTN a meta-analysis of randomized and high-quality non-randomized studies.pdf
2023 JAREEMIT_EMACO for treatment of gestational trophoblastic neoplasia A multinational multicenter study.pdf
2021 WINTER_Treatment of low-risk GTN.pdf
2021 BRAGA_Treatment of high-risk GTN and chemoresistance_relapsed disease.pdf
2017 KONG_Clinical characteristics and prognosis of ultra high-risk GTN patients.pdf